Published in Br J Dermatol on May 01, 1979
The effect of PUVA or UVB treatment on the PHA responsiveness of peripheral lymphocytes in vivo. Arch Dermatol Res (1983) 0.75
Enhancement of cutaneous delayed hypersensitivity reactions by a single exposure to UV-A or PUVA. Arch Dermatol Res (1982) 0.75
Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Diphtheria after visit to Russia. Lancet (1993) 2.74
Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy. N Engl J Med (1987) 2.47
The effect of health services on mortality: decline in death rates from amenable and non-amenable causes in Finland, 1969-81. Lancet (1986) 2.29
A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-beta-naphthylamide. Histochemie (1966) 1.98
Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants. Infect Immun (1998) 1.79
Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines. J Infect Dis (1998) 1.76
Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol (1994) 1.71
Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis (1995) 1.65
Patient awareness of seizures. Neurology (1996) 1.56
Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin Exp Immunol (1999) 1.56
Cross-reactivity of antibodies to type 6B and 6A polysaccharides of Streptococcus pneumoniae, evoked by pneumococcal conjugate vaccines, in infants. J Infect Dis (2001) 1.55
Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine. Lancet (1985) 1.52
Health services resources and their relation to mortality from causes amenable to health care intervention: a cross-national study. Int J Epidemiol (1988) 1.50
Effect of sport stress on lymphocyte transformation and antibody formation. Clin Exp Immunol (1978) 1.43
Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood. Vaccine (1999) 1.43
Serum C-reactive protein, erythrocyte sedimentation rate, and white blood cell count in acute hematogenous osteomyelitis of children. Pediatrics (1994) 1.40
A hog kidney aminopeptidase liberating N-terminal dipeptides. Partial purification and characteristics. Acta Chem Scand (1968) 1.38
Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory. Pediatr Infect Dis J (1998) 1.37
Human skin chymotryptic proteinase. Isolation and relation to cathepsin g and rat mast cell proteinase I. J Biol Chem (1983) 1.33
alpha-N-benzoylarginine-2-naphthylamide hydrolase (cathepsin B1 ?) from rat skin. II. Purification of the enzyme and demonstration of two inhibitors in the skin. Acta Chem Scand B (1975) 1.26
Distribution of a dipeptide naphthylamidase in rat tissues and its localisation by using diazo coupling and labeled antibody techniques. Histochemie (1969) 1.26
IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine (1999) 1.24
Serum insulin and growth hormone response to arginine infusion in healthy and psoriatic persons. Dermatologica (1973) 1.23
Purification and characterization of an aminopeptidase hydrolyzing glycyl-proline-naphthylamide. Hoppe Seylers Z Physiol Chem (1967) 1.22
Epidemiology of invasive Haemophilus influenzae type b disease among children in Finland before vaccination with Haemophilus influenzae type b conjugate vaccine. Pediatr Infect Dis J (1989) 1.20
The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child (1991) 1.20
The second Geneva Consensus: Recommendations for novel live TB vaccines. Vaccine (2010) 1.18
Infiltrative, ulcerative, and fistular lesions of the penis due to lymphogranuloma venereum. Br J Vener Dis (1973) 1.17
Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J Infect Dis (2000) 1.17
Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant. J Infect Dis (2001) 1.16
Anti-capsular polysaccharide antibody concentrations in saliva after immunization with Haemophilus influenzae type b conjugate vaccines. Pediatr Infect Dis J (1995) 1.15
Improvements in the method for the electron microscopic localization of arylsulphatase activity. Histochemie (1967) 1.15
A colour reaction for the differentiation of ascomycetous and hemibasidiomycetous yeasts. Antonie Van Leeuwenhoek (1976) 1.14
Effect of in ovo treatment with cyclophosphamide on lymphoid system in chicken. Cell Immunol (1974) 1.12
Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin. Scand J Immunol (1988) 1.11
A new micromethod for lymphocyte stimulation using whole blood. Immunol Commun (1975) 1.11
Pneumococcal conjugate vaccination in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine (1998) 1.10
Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J (1995) 1.10
Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J (1996) 1.10
Human skin proteases: separation and characterization of two alkaline proteases, one splitting trypsin and the other chymotrypsin substrates. Arch Dermatol Res (1975) 1.10
Immunoperoxidase and enzyme-histochemical demonstration of human skin tryptase in cutaneous mast cells in normal and mastocytoma skin. Arch Dermatol Res (1988) 1.09
Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J (2001) 1.09
Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta (1988) 1.08
Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus. Vaccine (2000) 1.08
New vaccines for the prevention of pneumococcal infections. Emerg Infect Dis (1997) 1.07
Issues about pertussis vaccines. Lancet (1998) 1.07
C-reactive protein compared with white blood cell count and erythrocyte sedimentation rate in the diagnosis of acute appendicitis in children. Acta Chir Scand (1986) 1.06
Risk factors for primary invasive pneumococcal disease among children in Finland. JAMA (1995) 1.06
Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms. Ann Intern Med (1989) 1.06
Immunogenicity in infants of a vaccine composed of Haemophilus influenzae type b capsular polysaccharide mixed with DPT or conjugated to diphtheria toxoid. J Infect Dis (1987) 1.06
Elastofibroma--a degenerative pseudotumor. Cancer (1969) 1.06
Human sweat kallikrein. Biochemical demonstration and chromatographic separation from several other esteropeptidases in the sweat. Acta Derm Venereol (1970) 1.06
Bacteremic urinary tract infection in children. Pediatr Infect Dis J (2000) 1.06
Haemophilus influenzae type b strains of outer membrane subtypes 1 and 1c cause different types of invasive disease. Lancet (1987) 1.05
Neonatal group B streptococcal disease in Finland: a ten-year nationwide study. Pediatr Infect Dis J (1999) 1.05
PCR assay for detecting Streptococcus pneumoniae in the middle ear of children with otitis media with effusion. Acta Otolaryngol (1996) 1.04
Spectrum of 2,836 cases of invasive bacterial or fungal infections in children: results of prospective nationwide five-year surveillance in Finland. Finnish Pediatric Invasive Infection Study Group. Clin Infect Dis (1995) 1.04
Human skin proteases. Separation and characterization of two acid proteases resembling cathepsin B1 and cathepsin D and of an inhibitor of cathepsin B1. Arch Dermatol Res (1976) 1.03
The decrease of hyaluronate synthesis by anti-inflammatory steroids in vitro. Br J Dermatol (1978) 1.02
Bacteremic pneumococcal pneumonia in children. Clin Infect Dis (1999) 1.02
Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children. Pediatr Infect Dis J (1995) 1.01
Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients. J Infect Dis (1995) 1.01
Peptidases in the skin. II. Demonstration and partial separation of several specific dipeptide naphthylamidases in the rat and human skin. Arch Klin Exp Dermatol (1969) 1.00
Antisense RNA inhibition of cathepsin L expression reduces tumorigenicity of malignant cells. Eur J Cancer (2000) 1.00
Human skin proteases. Fractionation and characterization. Arch Dermatol Forsch (1972) 0.99
Four isozymic forms of a peptidase resembling kallikrein purified from the rat submandibular gland. Hoppe Seylers Z Physiol Chem (1967) 0.99
Regional and social class variation in the relative risk of death from amenable causes in the city of Helsinki, 1980-1986. Int J Epidemiol (1995) 0.98
Proteolytic enzymes in the skin. 3. Studies on the extractability, stability and modifier characteristics of the caseinolytic enzymes in the rat skin. Acta Derm Venereol (1969) 0.98
Biological rhythm of cell-mediated immunity in man. Clin Exp Immunol (1976) 0.98
Impaired lymphocyte transformation after accidental trauma. Acta Chir Scand (1979) 0.98
Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child (1991) 0.97
Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatrics (1995) 0.97
Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med (1990) 0.96
Contact allergy to various components of topical preparations for treatment of external otitis. Acta Otolaryngol (1986) 0.96
Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age. J Infect Dis (1988) 0.96
Epidemiology of invasive Haemophilus influenzae type b disease. J Infect Dis (1992) 0.96
Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine (2000) 0.96
Peptidases in the skin. I. Biochemical demonstration of an aminopeptidase in rat skin specific for N-Terminal basic amino acids (Aminopeptidase B). Arch Klin Exp Dermatol (1968) 0.95
Human skin proteinases as inflammatory mediators. Br J Dermatol (1983) 0.95
Clinical comparison of the Haemophilus influenzae type B polysaccharide-diphtheria toxoid and the oligosaccharide-CRM197 protein vaccines in infancy. Arch Pediatr Adolesc Med (1994) 0.95
Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults. Vaccine (2001) 0.95
High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. J Infect Dis (1992) 0.95
Immunogenicity of Haemophilus influenzae oligosaccharide-protein and polysaccharide-protein conjugate vaccination of children at 4, 6, and 14 months of age. Pediatrics (1989) 0.94
Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine (1998) 0.94
Lymphocyte stimulation in vitro by proteinases and its augmentation with a proteinase binding factor from human skin. Arch Dermatol Res (1978) 0.94
Surveillance of influenza in Finland during the 2009 pandemic, 10 May 2009 to 8 March 2010. Euro Surveill (2011) 0.94
Cysteine proteinase inhibitors in psoriatic epidermis. Arch Dermatol Res (1983) 0.94
Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies. Pediatr Infect Dis J (1999) 0.93
Risk factors of invasive Haemophilus influenzae type b disease among children in Finland. J Pediatr (1989) 0.93
Enzyme-linked immunosorbent assay (ELISA) for antibodies to purified protein derivative of tuberculin (PPD). IgM-, IgA- and IgG- anti-PPD antibodies in active pulmonary tuberculosis. Eur J Respir Dis (1982) 0.92
Polymorphonuclear leukocyte function in psoriasis: chemotaxis, chemokinesis, beta-adrenergic receptors, and proteolytic enzymes of polymorphonuclear leukocytes in the peripheral blood from psoriatic patients. J Invest Dermatol (1983) 0.92
Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Vaccine (1999) 0.92
Effect of strenuous physical stress on circulating lymphocyte number and function before and after training. J Clin Lab Immunol (1982) 0.91